Rockefeller Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-288,534
| Closed | -$9.22M | – | 4582 |
|
|
2022
Q2 | $9.22M | Buy |
288,534
+55,542
| +24% | +$1.77M | 0.05% | 366 |
|
|
2022
Q1 | $8.07M | Buy |
232,992
+9,086
| +4% | +$315K | 0.04% | 422 |
|
|
2021
Q4 | $6.55M | Buy |
223,906
+14,033
| +7% | +$411K | 0.03% | 469 |
|
|
2021
Q3 | $5.35M | Buy |
209,873
+46,392
| +28% | +$1.18M | 0.03% | 460 |
|
|
2021
Q2 | $5.73M | Buy |
163,481
+139,931
| +594% | +$4.9M | 0.03% | 418 |
|
|
2021
Q1 | $959K | Buy |
23,550
+11,300
| +92% | +$460K | 0.01% | 796 |
|
|
2020
Q4 | $530K | Sell |
12,250
-5,296
| -30% | -$229K | ﹤0.01% | 895 |
|
|
2020
Q3 | $967K | Buy |
17,546
+7,286
| +71% | +$402K | 0.01% | 606 |
|
|
2020
Q2 | $648K | Buy |
10,260
+10,171
| +11,428% | +$642K | 0.01% | 633 |
|
|
2020
Q1 | $5K | Buy |
89
+86
| +2,867% | +$4.83K | ﹤0.01% | 1981 |
|
|
2019
Q4 | $0 | Buy |
+3
| New | – | ﹤0.01% | 2259 |
|